Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial

Mikhail N. Kosiborod, Pardeep S. Jhund, Kieran F. Docherty, Mirta Diez, Mark C. Petrie, Subodh Verma, Jose C. Nicolau, Béla Merkely, Masafumi Kitakaze, David L. DeMets, Silvio E. Inzucchi, Lars Køber, Felipe A. Martinez, Piotr Ponikowski, Marc S. Sabatine, Scott D. Solomon, Olof Bengtsson, Daniel Lindholm, Anna Niklasson, Mikaela SjöstrandAnna Maria Langkilde, John J.V. McMurray

Research output: Contribution to journalArticle

8 Citations (Scopus)

Fingerprint Dive into the research topics of 'Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences